Phone app aims to clear COVID brain fog
NCT ID NCT06315894
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a 12-week smartphone program called SuperCAP for people with post-COVID syndrome. The program includes daily games, exercises, and videos to improve thinking, mood, and daily function. Sixty adults with ongoing cognitive complaints took part, and researchers measured changes in self-reported thinking abilities and depression symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SuperCAP Program (a supervised computerized active program delivered via cell phone)
- What this could lead to
- If it works, this could offer a practical, home-based way to ease brain fog and emotional struggles after COVID-19.
- What could go wrong
- This is a small, completed study with only 60 participants and no control group, so results may not be widely applicable. The program requires daily effort and a positive attitude toward technology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST COVID CONDITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Germans Trias I Pujol Hospital
Badalona, Barcelona, 08916, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Micro-Choices, macro impact? a novel behavioral approach takes on fatigue
- Fish oil and remote rehab: a new hope for long COVID sufferers?
- Brain training app takes on long COVID disability
- Nerve block shot could ease Long-COVID brain fog and fatigue?
- Study tracks lingering COVID symptoms in 400 Pre-Surgery patients
- Can these drugs ease long COVID? new trial aims to find out